CRISPR/Cas9-mediated Mutagenesis at Microhomologous Regions of Human Mitochondrial Genome
Overview
Affiliations
Genetic manipulation of mitochondrial DNA (mtDNA) could be harnessed for deciphering the gene function of mitochondria; it also acts as a promising approach for the therapeutic correction of pathogenic mutation in mtDNA. However, there is still a lack of direct evidence showing the edited mutagenesis within human mtDNA by clustered regularly interspaced short palindromic repeats-associated protein 9 (CRISPR/Cas9). Here, using engineered CRISPR/Cas9, we observed numerous insertion/deletion (InDel) events at several mtDNA microhomologous regions, which were triggered specifically by double-strand break (DSB) lesions within mtDNA. InDel mutagenesis was significantly improved by sgRNA multiplexing and a DSB repair inhibitor, iniparib, demonstrating the evidence of rewiring DSB repair status to manipulate mtDNA using CRISPR/Cas9. These findings would provide novel insights into mtDNA mutagenesis and mitochondrial gene therapy for diseases involving pathogenic mtDNA.
He W, Dong S, Zeng Q Molecules. 2025; 30(5).
PMID: 40076250 PMC: 11902231. DOI: 10.3390/molecules30051025.
Engineered mitochondria in diseases: mechanisms, strategies, and applications.
Li M, Wu L, Si H, Wu Y, Liu Y, Zeng Y Signal Transduct Target Ther. 2025; 10(1):71.
PMID: 40025039 PMC: 11873319. DOI: 10.1038/s41392-024-02081-y.
Streamlined process for effective and strand-selective mitochondrial base editing using mitoBEs.
Zhang X, Yi Z, Tang W, Wei W Biophys Rep. 2024; 10(4):191-200.
PMID: 39281197 PMC: 11399887. DOI: 10.52601/bpr.2024.240010.
The Roles of CircRNAs in Mitochondria.
Liu D, Zhou X, He Y, Zhao J J Cancer. 2024; 15(9):2759-2769.
PMID: 38577612 PMC: 10988319. DOI: 10.7150/jca.92111.
Ruan H, Li X, Zhou L, Zheng Z, Hua R, Wang X Sci China Life Sci. 2023; 67(2):360-378.
PMID: 37815699 DOI: 10.1007/s11427-022-2365-1.